Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Nerac logo Customer Access
  • Home
  • What We Do
    • Nerac IPDex™
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us

Medical Device & Healthcare

Medical Devices: New Applications for Old Innovations

By Helga Weires, Nerac Analyst
Originally published June 19, 2017
This article explores new applications for old innovations in medical devices.
Read More

Regenerative Medicine: A New Kind of Cellular Service

By Tyler Stahl, M.S., Nerac Analyst
Originally published April 27, 2017
This article explores recent trends in the developing field of tissue engineering and regenerative medicine.
Read More

State of the Art for Medical Devices – Applying the Requirements of MEDDEV 2.7/1 Rev. 4

By Nerac Regulatory Analysts
Originally published July 31, 2018
This article explores how to establish and document state of the art in terms of CER requirements.
Read More

The Regulatory Environment for 3D Printing in the Healthcare Field

By Erica Kramer,Ph.D., Nerac Analyst
Originally published January 19, 2017
Learn more about 3D printing in the medical field and and key conclusions on regulatory issues in the healthcare market.
Read More

Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A 3-Part Nerac Perspective

By Richard Conforti, M.S.
Originally published August 15, 2016
This is a 3-part series of articles on the 2014 Chinese Food and Drug Administration(CFDA), providing an update on their medical device regulations. The first article discussed which devices can be used to support your submission to the CFDA. The second article addressed the changes to selecting clinical literature. The third article describes the final clinical literature report.
Read all three here

Risk Assessment and the Value of a Comprehensive Post-Market Surveillance Program

By Carol Young, Nerac Analyst
Originally Published: January 20, 2016
This article explores risk assessment and the value of a comprehensive post-market surveillance program.
Read More

Smartphone Health Sensing – Beyond the Hype.

By Kevin Closson, M.S., MBA, Nerac Analyst,
Originally Published: November 6, 2015
This article looks into some of the realities of the health sensing market.
Read More

Patents and Medical Devices: Protecting your Business Through Intellectual Property

By Ron Sills M.S., Nerac Analyst,
Originally Published: July 6th, 2015
This article describes how medical device manufacturers can and should protect their products and business interests through patent protection. This includes not only patent protection of their own intellectual property, but actively monitoring the industry to ensure there is no infringement on their intellectual property.
Read More

Establishing State-of-the-art Compliance for Medical Devices

By Ron Sills, M.S., Nerac Analyst
Originally Published: June 22nd, 2015
The regulatory changes occurring in the EU have resulted in an increased scrutiny for many medical device manufacturers. In Nerac’s experience, notified bodies have shown an increased emphasis on the clinical evaluation reports which support the safety and performance of approved devices.
Read More

Notified Body Audit Trends: Be in the Know!

By Donna Mitchell-Magaldi, Nerac Analyst
Originally Published: February 10, 2015
With Notified Bodies being periodically audited, it is important to understand that they will be reviewing your technical documentation with a much more critical approach. As the new regulatory framework is passed and implemented, further changes will increase Notified Body expectations. Auditors will continue to identify areas of concern and medical device manufacturers will need to stay vigilant regarding the findings of the Notified Body auditors in order to keep ahead of the expectations. Make sure you understand these trends!! Read More

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2023 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000